GANX · Company research
Gain Therapeutics, Inc. Common Stock (GANX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Gain Therapeutics, Inc. (GANX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| Why Is GANX Stock Rallying 22% After Hours? - Stocktwits | Why Is GANX Stock Rallying 22% After Hours? Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| Gain Therapeutics Inc (NASDAQ: GANX) Share Price, GANX Stock News, GANX Share Price & Updates - kalkine.ca | Gain Therapeutics Inc (NASDAQ: GANX) Share Price, GANX Stock News, GANX Share Price & Updates kalkine.ca | View source ↗ | kalkine.ca | Oct 7, 2026 | neutral | 0 | 0.6 |
| Gain Therapeutics, Inc. (NASDAQ:GANX) Stock Has Average Price Target of $7.50 - MarketBeat | Gain Therapeutics, Inc. (NASDAQ:GANX) Stock Has Average Price Target of $7.50 MarketBeat | View source ↗ | MarketBeat | Oct 4, 2026 | neutral | 0 | 0.6 |
| Long-term data on a Parkinson’s drug candidate will be presented in Seoul. - Stock Titan | Long-term data on a Parkinson’s drug candidate will be presented in Seoul. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| A biotech CEO will join a neuroscience panel in New York - Stock Titan | A biotech CEO will join a neuroscience panel in New York Stock Titan | View source ↗ | Stock Titan | Sep 17, 2026 | neutral | 0 | 0.6 |
| H.C. Wainwright reiterates Gain Therapeutics stock rating on FDA approval - Investing.com | H.C. Wainwright reiterates Gain Therapeutics stock rating on FDA approval Investing.com | View source ↗ | Investing.com | Jul 1, 2026 | neutral | 0 | 0.6 |
| Why Is GANX Stock Rallying 22% After Hours? - TradingView | Why Is GANX Stock Rallying 22% After Hours? TradingView | View source ↗ | TradingView | Jun 29, 2026 | neutral | 0 | 0.6 |
| 3 Clinical-Stage Biotech Stocks Worth Watching In Parkinson's Research - Simply Wall Street | 3 Clinical-Stage Biotech Stocks Worth Watching In Parkinson's Research Simply Wall Street | View source ↗ | Simply Wall Street | Jun 26, 2026 | neutral | 0 | 0.6 |
| GANX Forecast — Price Target — Prediction for 2027 - TradingView | GANX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| 3 Parkinson's Biotech Stocks Analysts Think Are Wildly Mispriced - Simply Wall Street | 3 Parkinson's Biotech Stocks Analysts Think Are Wildly Mispriced Simply Wall Street | View source ↗ | Simply Wall Street | May 22, 2026 | neutral | 0 | 0.6 |
| GANX Should I Buy - Intellectia AI | GANX Should I Buy Intellectia AI | View source ↗ | Intellectia AI | Apr 11, 2026 | neutral | 0 | 0.6 |
| Gain Therapeutics, Inc. Common Stock (GANX) Stock Price: Oct 7 Close $1.67 - Gotrade | Gain Therapeutics, Inc. Common Stock (GANX) Stock Price: Oct 7 Close $1.67 Gotrade | View source ↗ | Gotrade | Mar 10, 2026 | neutral | 0 | 0.6 |
| Gain Therapeutics, Inc. (GANX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Gain Therapeutics, Inc. (GANX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Dec 29, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.